The waxing and waning of the coronavirus pandemic in Europe shows new danger areas emerging

Europe has seen major changes in coronavirus case rates over the last two months.  More...

Europe: EMA assessing reports of Guillain-Barre syndrome with AstraZeneca’s coronavirus vaccine VaxZevria

“As part of the review of the regular pandemic summary safety reports for Vaxzevria, AstraZeneca’s Covid-19 vaccine, the PRAC is analysing data provided by the marketing authorisation holder on cases of Guillain-Barre syndrome (GBS) [1] reported following vaccination.  More...